198 related articles for article (PubMed ID: 37144531)
1. Advances in the genetics of nonalcoholic fatty liver disease.
Ajmera V; Loomba R
Curr Opin Gastroenterol; 2023 May; 39(3):150-155. PubMed ID: 37144531
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.
Bianco C; Jamialahmadi O; Pelusi S; Baselli G; Dongiovanni P; Zanoni I; Santoro L; Maier S; Liguori A; Meroni M; Borroni V; D'Ambrosio R; Spagnuolo R; Alisi A; Federico A; Bugianesi E; Petta S; Miele L; Vespasiani-Gentilucci U; Anstee QM; Stickel F; Hampe J; Fischer J; Berg T; Fracanzani AL; Soardo G; Reeves H; Prati D; Romeo S; Valenti L
J Hepatol; 2021 Apr; 74(4):775-782. PubMed ID: 33248170
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease.
Paternostro R; Staufer K; Traussnigg S; Stättermayer AF; Halilbasic E; Keritam O; Meyer EL; Stift J; Wrba F; Sipos B; Canbay A; Schlattjan M; Aigner E; Datz C; Stickel F; Schafmayer C; Hampe J; Buch S; Prager G; Munda P; Mandorfer M; Ferenci P; Trauner M
Hepatol Int; 2021 Aug; 15(4):922-933. PubMed ID: 34076851
[TBL] [Abstract][Full Text] [Related]
4. Genetic and Metabolic Characteristics of Lean Nonalcoholic Fatty Liver Disease in a Korean Health Examinee Cohort.
Park H; Yoon EL; Chung GE; Choe EK; Bae JH; Choi SH; Kim M; Hwang W; Kim HL; Yang SY; Jun DW
Gut Liver; 2024 Mar; 18(2):316-327. PubMed ID: 37560798
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
Anstee QM; Darlay R; Cockell S; Meroni M; Govaere O; Tiniakos D; Burt AD; Bedossa P; Palmer J; Liu YL; Aithal GP; Allison M; Yki-Järvinen H; Vacca M; Dufour JF; Invernizzi P; Prati D; Ekstedt M; Kechagias S; Francque S; Petta S; Bugianesi E; Clement K; Ratziu V; Schattenberg JM; Valenti L; Day CP; Cordell HJ; Daly AK;
J Hepatol; 2020 Sep; 73(3):505-515. PubMed ID: 32298765
[TBL] [Abstract][Full Text] [Related]
6. NAFLD: genetics and its clinical implications.
Sharma D; Mandal P
Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):102003. PubMed ID: 35963605
[TBL] [Abstract][Full Text] [Related]
7. Genetic predisposition in nonalcoholic fatty liver disease.
Sookoian S; Pirola CJ
Clin Mol Hepatol; 2017 Mar; 23(1):1-12. PubMed ID: 28268262
[TBL] [Abstract][Full Text] [Related]
8. Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease.
Seko Y; Yamaguchi K; Tochiki N; Yano K; Takahashi A; Okishio S; Kataoka S; Okuda K; Umemura A; Moriguchi M; Tanaka S; Mori K; Okanoue T; Itoh Y
Liver Int; 2020 Jul; 40(7):1686-1692. PubMed ID: 32342668
[TBL] [Abstract][Full Text] [Related]
9. Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications.
Martin K; Hatab A; Athwal VS; Jokl E; Piper Hanley K
Curr Diab Rep; 2021 Feb; 21(3):8. PubMed ID: 33544287
[TBL] [Abstract][Full Text] [Related]
10. Genetic Markers Predisposing to Nonalcoholic Steatohepatitis.
Sohal A; Chaudhry H; Kowdley KV
Clin Liver Dis; 2023 May; 27(2):333-352. PubMed ID: 37024211
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease.
Chen Y; Du X; Kuppa A; Feitosa MF; Bielak LF; O'Connell JR; Musani SK; Guo X; Kahali B; Chen VL; Smith AV; Ryan KA; Eirksdottir G; Allison MA; Bowden DW; Budoff MJ; Carr JJ; Chen YI; Taylor KD; Oliveri A; Correa A; Crudup BF; Kardia SLR; Mosley TH; Norris JM; Terry JG; Rotter JI; Wagenknecht LE; Halligan BD; Young KA; Hokanson JE; Washko GR; Gudnason V; Province MA; Peyser PA; Palmer ND; Speliotes EK
Nat Genet; 2023 Oct; 55(10):1640-1650. PubMed ID: 37709864
[TBL] [Abstract][Full Text] [Related]
12. Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis.
Carlsson B; Lindén D; Brolén G; Liljeblad M; Bjursell M; Romeo S; Loomba R
Aliment Pharmacol Ther; 2020 Jun; 51(12):1305-1320. PubMed ID: 32383295
[TBL] [Abstract][Full Text] [Related]
13. Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease.
Taliento AE; Dallio M; Federico A; Prati D; Valenti L
Int J Environ Res Public Health; 2019 Aug; 16(15):. PubMed ID: 31375010
[TBL] [Abstract][Full Text] [Related]
14. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
[TBL] [Abstract][Full Text] [Related]
15. Update on NAFLD genetics: From new variants to the clinic.
Trépo E; Valenti L
J Hepatol; 2020 Jun; 72(6):1196-1209. PubMed ID: 32145256
[TBL] [Abstract][Full Text] [Related]
16. Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease.
Wu JT; Liu SS; Xie XJ; Liu Q; Xin YN; Xuan SY
Lipids Health Dis; 2020 Feb; 19(1):29. PubMed ID: 32093693
[TBL] [Abstract][Full Text] [Related]
17. TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models.
Longo M; Meroni M; Paolini E; Erconi V; Carli F; Fortunato F; Ronchi D; Piciotti R; Sabatini S; Macchi C; Alisi A; Miele L; Soardo G; Comi GP; Valenti L; Ruscica M; Fracanzani AL; Gastaldelli A; Dongiovanni P
Cell Mol Gastroenterol Hepatol; 2022; 13(3):759-788. PubMed ID: 34823063
[TBL] [Abstract][Full Text] [Related]
18. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
[TBL] [Abstract][Full Text] [Related]
20. Pediatric non-alcoholic fatty liver disease and kidney function: Effect of
Di Sessa A; Umano GR; Cirillo G; Passaro AP; Verde V; Cozzolino D; Guarino S; Marzuillo P; Miraglia Del Giudice E
World J Gastroenterol; 2020 Sep; 26(36):5474-5483. PubMed ID: 33024398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
